Category: CNS/Neurology
United States CNS/Neurology
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
The U.S. Autism Treatment Centers Market
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
The U.S. Autism Treatment Centers Market: DataPack
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
United States Speech Therapy Market, By Age Group (Children (0-17), Young Adults (18-25), Adults (26-64), Elders (65 and Above)), By Indication (Speech Disorders, Language Disorders, Apraxia, Autism Spectrum Disorder (ASD), and Others), By End-User (Hospitals, Clinics, Rehabilitation Centre, and Others)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Clinics, Rehabilitation Centre, and Others)Trend Analysis, Competitive Market Share & Forecast, 2018-2028 United States Speech Therapy Market to Reach USD 6.35 Billion by 2028 United States Speech Therapy Market is flourishing owing to the rising ... Read More
-
U.S. Opioids Market, by Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone), by Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids ... Read More
-
U.S. Speech Therapy Market, by Age Group (Children and Adults), by Indication (Speech Disorders, Language Disorders, Apraxia, Autism Spectrum Disorder (ASD), and Others), and by End User (Hospitals, Clinics, Rehabilitation Centers, and Others) - Size, Sha
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 The demand of speech therapy has been dynamically increasing in the U.S., owing to increasing prevalence of language and speech disorders. The National Institute on Deafness and ... Read More
-
U.S. Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium, Iodinated), By Application (Cardiovascular, Neurological Disorders), By Modality (MRI, X-ray/CT Scan), And Segment Forecasts, 2022 - 2030
... & Trends The U.S. contrast media market is anticipated to reach USD3.36 billion by 2030, registering a CAGR of 4.12% over the forecast period, according to a new report by Grand View Research, Inc. The ... Read More
-
U.S. Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin’s, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More
-
U.S. Hospice Market Size, Share & Trends Analysis Report By Location (Hospice Center, Home Hospice Care), By Type (RHC, CHC), By Diagnosis (Dementia, Cancer, Respiratory, Stroke), And Segment Forecasts, 2022 - 2030
... a CAGR of 8.20% over the forecast period. The rising healthcare expenditure, awareness about the benefits of palliative and end-of-life care, and favorable reimbursements are some of the major growth drivers. According to the NHPCO, ... Read More
-
U.S. Post-acute Care Market Size By Services (Inpatient Rehabilitation Facilities [IRF], Skilled Nursing Facilities [SNFs], Home Health Agencies [HHAs], Hospice Care, Long-term Care Hospitals [LTCHs]), By Conditions (Amputations, Wound Management, Brain Injury, Spinal Cord Injury, Neurological Disorders), By Age {Elderly (65 years & older), Adult (45-64 years)}, Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022- 2028
... Neurological Disorders), By Age {Elderly (65 years & older), Adult (45-64 years)}, Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022- 2028 The U.S. post-acute care market is ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 2028
... grow at a CAGR of 13.0% from 2021 to 2028 to reach $2.01 billion by 2028 Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the ... Read More
-
United States Neurology Devices Market- Growth, Trends, and Forecasts (2022 - 2027)
... the growth of the market are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, an increase in R&D in the field of neuro therapies, and the rising aging population. ... Read More
Research Assistance
